BETH HELLSTERN: Open Payments
NPI 1407810401 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 37 payments from 18 companies in 2025. Trend: 2023 $891 · 2024 $832 · 2025 $735
Food & beverage: $623Education: $112
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $207 |
| ABBVIE INC. | 5 | $92 |
| PFIZER INC. | 4 | $70 |
| Incyte Corporation | 4 | $69 |
| Lilly USA, LLC | 2 | $42 |
| Galderma Laboratories, L.P. | 2 | $32 |
| UCB, Inc. | 2 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: TREMFYA, CIBINQO, OPZELURA, SKYRIZI, EBGLYSS, RINVOQ, NEMLUVIO, Bimzelx.
Industry payments across NJ — which companies pay providers there.
